Peer Review History
| Original SubmissionMarch 12, 2026 |
|---|
|
Dear Dr. Choi-Kain, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== Thank you for submitting your very interesting manuscript. Please address the reviewers' comments. ============================== Please submit your revised manuscript by May 30 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Hong Wang Fung Academic Editor PLOS One Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uplo`aded) as separate "supporting information" files. 3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 4. In the online submission form you indicate that your data is not available for proprietary reasons and have provided a contact point for accessing this data. Please note that your current contact point is a co-author on this manuscript. According to our Data Policy, the contact point must not be an author on the manuscript and must be an institutional contact, ideally not an individual. Please revise your data statement to a non-author institutional point of contact, such as a data access or ethics committee, and send this to us via return email. Please also include contact information for the third party organization, and please include the full citation of where the data can be found. 5. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 6. Please upload a new copy of Figures 2-3, and Supporting Information Table 1 as the detail is not clear. Please follow the link for more information: https://journals.plos.org/plosone/s/figures 7. We note that the original protocol that you have uploaded as a Supporting Information file contains an institutional logo. As this logo is likely copyrighted, we ask that you please remove it from this file and upload an updated version upon resubmission. 8. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: Thank you for submitting your very interesting manuscript. Please address the reviewers' comments. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Partly Reviewer #4: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: No Reviewer #2: Yes Reviewer #3: No Reviewer #4: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** Reviewer #1: This study addresses an important and challenging population and demonstrates several notable strengths. The inclusion of lived experience input is particularly valuable. Research with individuals with BPD is inherently difficult due to ethical considerations and risk management, which complicates recruitment, retention, and safety monitoring. Despite these challenges, the authors successfully implemented a fully online intervention and assessment protocol, demonstrating feasibility and acceptability in a population that is often hard to engage. Nonetheless, several methodological and reporting issues limit interpretation and generalizability. The authors appear aware of these limitations, and the preliminary data are promising. Please see the attached comments for specific revisions and clarifications regarding diagnosis verification, intervention adherence, measurement, safety monitoring, statistical approach, attrition, and potential confounds. I look forward to seeing this work progress. Reviewer #2: This RCT takes an interesting and possibly very useful concept of using virtual tools to ameliorate the impact of BPD prior to receiving long term treatment. Overall it is well written and comprehensive in describing methods, and results. Most of the concerns I had have been addressed in the limitation section. One point to clarify is when you included those that had taken some form or duration of DBT and MBT did you consider the possible confounding effect on the response to the psycho education (with or without feedback) Also consider summarizing the introduction, it’s a bit long. Reviewer #3: This is a feasibility and safety of a randomized controlled trial protocol of online psychoeducation and personalized feedback as an immediate first step of care for BPD. Some comments for the authors: 1) While at this stage it might be late - consider title incoporates that this is randomised feasibility study - for searchability. 2) They are some differences between pilot and feasibility studies and these are used interchangeably in the manuscript - can this is be clarified. For example, feasibility studies usually assess parameters such as recruitment,retention,acceptability of intervention (.i.e as you have noted in lines 317 - 326). Pilot studies are essentially a study, e.g mimicing the larger study - however in this manuscript there seems to a combination of both with some statistical formal testing which seems inappropriate. 3) There seems to be no justification of the number of people (sample size) for the study - even though they are planned significance tests 4) Can there more information around the randomisation process (lines 243 - 248 talks about having fixed parameters to ensure balance - but this would be determined in the computergenerated scehedule, i.e having three groups with stratification as well - can more information be added to explain the rationale for this - or more clarity please. how was allocation concealment achieved? 5) Assuming this is RCT feasibility study - there should be no between group differences at baseline since any differences are due to chance. 6) Was there a statistical analysis plan, prior to final analyses, 7) Any independent committee reviewing/monitoring safety of these participants. 8) How was missing data handled? 9) Table 1 - all baseline symptoms, can you also report other metrics, i.e median range - since sample sizes are small, removed p-values 10) Table 3 - Primary outcomes - firstly maybe have a foot note for meaning og Time B, C, D and really the primary outcomes of the feasibility studies should be the ones mentioned, i.e recruitment etc - can this be clarified. Reviewer #4: Thank you for the opportunity to review the manuscript entitled "Online psychoeducation and assessment for borderline personality disorder as a first step of care: A pilot study assessing safety, feasibility, and mechanisms of change". This is a timely study that warrants more attention from the field of mental healthcare. Below are my comments regarding the current manuscript: 1. Please cite the reference for the characteristic traits of BPD (line 67-69). 2. Please elaborate on the personal & societal costs mentioned (line 69-70). 3. Please provide evidence for the claim regarding availability of recommended therapies for BPD (75-78). 4. Please provide the internal consistency of the self-developed Knowledge of BPD scale. 5. I wonder if there are any qualitative data that can be triangulated to further enhance the quantitative findings. ********** what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No Reviewer #3: No Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.
|
| Revision 1 |
|
Online psychoeducation and assessment for borderline personality disorder as a first step of care: A pilot study assessing safety, feasibility, and mechanisms of change PONE-D-26-11438R1 Dear Dr. Choi-Kain, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Hong Wang Fung Academic Editor PLOS One Additional Editor Comments (optional): Our reviewers have now reviewed your revised submission and recommended publication in its current form. Thank you for your contributions. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #3: Yes ********** Reviewer #3: All commentd addressed. ********** what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #3: No ********** |
| Formally Accepted |
|
PONE-D-26-11438R1 PLOS One Dear Dr. Choi-Kain, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Hong Wang Fung Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .